Back


28/11/2017
Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness
Auris Medical Holding AG(NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced top-line results from the HEALOS Phase 3 clinical trial [...]




X

X